IMCD stock
IMCD.ASAMSIMCD N.V., Basic MaterialsISIN NL0010801007
65Score 65 out of 100, Neutral
Price and trend
79 / 100
Price history
+26% in one yearThe chart shows daily closes over 12 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.
Above the 200-day line: the price is 14% above it.
Since May 2026 the 50-day line has been above the 200-day line; the trend has turned up.
Normal: the price is neither overheated nor sold off (RSI 61).
The price is at its 52-week high. Largest decline in 12 years: 66% (December 2021 to March 2026).
Chart figures for advanced users
- SMA 50$110.52
- Average price of the last 50 trading days, shows the short-term trend.
- SMA 200$101.72
- Average price of the last 200 trading days, shows the long-term trend.
- RSI (14)61
- Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
- MACDbelow the signal line
- Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
- Support$78.00
- The lowest closing price of the last twelve months.
- Resistance$116.50
- The highest closing price of the last twelve months.
Snapshot
Computed from the data by fixed rules, no AI
- IMCD N.V. belongs to the Chemicals (Specialty) industry (Netherlands) and, with a market value of $6.83B, is number 45 of 108 companies in its industry on MEQIRI.
- In fiscal 2025 it reported revenue of $5.32B (up 1.1% year on year) and earnings of $242.1M (down 21.8%).
- For fiscal 2026, analysts expect on average revenue of $5.76B (up 8.3%) and adjusted earnings per share of $6.27.
Show more
- MEQIRI Score 65 out of 100 (Neutral): rank 140 of 467 in Basic Materials, median 58.
- The P/E is 26.7 (Chemicals (Specialty) median 24.4, own median of recent years 30.1).
- Our model puts fair value at $140.27, with the price 19% below it.
In plain words
The numbers on this page in plain words, written by an AI
Strengths
- Earnings turn into cashFree cash flow 161% of earnings over the last 12 months.Fundamentals 86
- Consistently profitableProfit in all 10 fiscal years from 2016 to 2025.Fundamentals 86
- Growing faster than its industryRevenue up 11.5% a year since 2020, Chemicals (Specialty) median 6%.Growth 70
Weaknesses
None of our weakness checks flags anything. Crash risk is measured separately.
Its standout strengths are fundamentals and technical analysis, while capital allocation and profitability hold the score back.
Daily figure as of 12 Nov 2026
How the score is calculatedScore overview
Fundamentals are strong, with stable profits and strong cash generation.
Score history
The full history of up to 20 years comes with MEQIRI Pro.
See plansCrash risk medium
How well MEQIRI warnsIn the middle among smaller stocks.
From 2016 to 2025, 20 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.
What drives the risk
- cyclical sector (energy or materials), as a group, crashed more often in the backtest
What lowers it
- solid fundamentals
- price near its 52-week high
Valuation
Valuation signal
Modestly undervaluedClosing price of 11 Nov 2026, used by the daily score.
In our model the price counts as cheap below $107.90 and expensive above $200.39 (uncertainty medium, based on the price swings of the past year).
The two parts of the fair value come to $174.91 (cash-flow model) and $105.64 (industry comparison), and the gap between them shows how uncertain the estimate is.
Calculated with a cost of equity of 7.3%. At 8.3% the fair value would be $125.59, at 6.3% it would be $162.30.
Valuation metrics
Half from the cash-flow model, half from earnings times the industry P/E (24.4).
Calculate with your own assumptionsCompany performance
This shows several years of history with an automatic assessment.
Revenue
In the twelve months to 30 Jun 2026, revenue rose 2.4% on the twelve months before. Revenue has grown strongly since 2011, at around 13% per year.
Margins
- Gross margin
- Operating margin
- Net margin
In fiscal 2025: gross 10%, operating 8%, net 5%.
Debt & balance sheet
latest quarterModerate debt, and interest is adequately covered.
Earnings
- Next earnings
- 19 Feb 2027in 99 days
- Last reported
- 5 Nov 2026EPS reported $2.68 (expected $3.78)below expectations
Analyst estimates
Earnings estimates have barely changed since 15 Oct 2026.
- Earnings per share
- $6.270.0%
- Revenue
- $5.76B0.0%
- Earnings per share
- $6.750.0%
- Revenue
- $6.01B0.0%
MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.
Company outlook confirmed
Share price after the results: +9.0%Management feels on a better track to deliver the expected growth numbers; no concrete guidance figures were given.
“And I feel that we're on a better track to deliver the kind of growth numbers that we expect going forward.”The outlook is not part of the score and not a recommendation to buy or sell.
From the earnings call on 29 Jul 2026 (fiscal Q2 2026), read by AI.
What happened at IMCD
The key events of the last six months from our own data. A click takes you to the matching card.
Sector comparison
467 rated companies in Basic Materials
- This company
- 65
- Sector median
- 58
Categories against the sector median
The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.
Competitors in Chemicals (Specialty)
The next larger and next smaller companies by market value
- Eastman ChemicalEMN $7.6B60
- China Rare Earth Resources and Technology000831.SZ $7.57B52
- Hengyi Petrochemical000703.SZ $7.14B54
- Huafon Chemical002064.SZ $6.92B60
- Shanghai Putailai New Energy Technology603659.SS $6.6B58
- SOLSOL.MI $6.42B68
- NewMarketNEU $6.42B72
- Fuchs PetrolubFPE3.DE $6.34B74
ETFs that hold IMCD
Held by 43 ETFs on Xetra. Shown per index: the ETF with the largest weight.
| ETF | Weight | Cost | Fund size |
|---|---|---|---|
| iShares STOXX Europe 600 Chemicals UCITS ETF (DE)EXV7 | 2.58% | 0.46% | €114.14M |
| Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF DISTLGWU | 1.26% | 0.40% | €575.19M |
| UBS MSCI EMU Small Cap UCITS ETF EUR disUEFD | 1.13% | 0.28% | €627.81M |
Show 5 more
| iShares EURO STOXX Mid UCITS ETFIQQM | 0.74% | 0.40% | €558.1M |
| Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistX026 | 0.50% | 0.23% | €319.31M |
| Xtrackers MSCI Europe Small Cap UCITS ETF 1CXXSC | 0.42% | 0.30% | €3.43B |
| WisdomTree Europe Equity UCITS ETF USD HedgedWTDH | 0.37% | 0.58% | €117.51M |
| iShares STOXX Europe Mid 200 UCITS ETF (DE)EXSD | 0.36% | 0.20% | €634.13M |
Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).
Data status and sources
- Score
- Daily value of 12 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 11 Nov 2026 ($1 = €0.8987)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 21 Feb 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.